TECH New eye therapy approved in China

TECH

New eye therapy approved in China

By Zhou Wenting | China Daily

17:42, August 21, 2020

China's medicine authority recently approved an eye therapy to be marketed in China.

[Photo/oxervate.com]

Developed by Dompé, an Italian biopharmaceutical company, the therapy is designed to treat neurotropic keratitis, or NK, an eye disease that could lead to blindness.

NK is caused by the impaired function of the corneal nerves. Clinical symptoms include the decline or absence in corneal sensation, following which the development of stromal ulcers, dissolution and perforation could take place. In severe cases, patients lose their vision.

The therapy, according to the company, will promote the healing of ocular surface tissues and regenerate corneal nerves.

Medical experts have urged the public to take pre-emptive measures, such as being prudent in the use of eye drops with preservatives and not wearing contact lens for prolonged periods.

Related Stories

Terms of Service & Privacy Policy

We have updated our privacy policy to comply with the latest laws and regulations. The updated policy explains the mechanism of how we collect and treat your personal data. You can learn more about the rights you have by reading our terms of service. Please read them carefully. By clicking AGREE, you indicate that you have read and agreed to our privacy policies

Agree and continue